CD81 and hepatocellular carcinoma: CD81 is associated with differentiation and metastasis of HCC 46 and, more recently, with glucose intolerance and insulin resistance, so it is suggested as an useful index to predict the risk of future metabolic disorders or the future success of efforts to control body weigh 47.